The tumor-released EVs induce neutrophil migration toward the tumor microenvironment through the chemokine receptor CXCR2/CXCL8 (IL8) axis, activating the PI3K-AKT pathway in the neutrophils. This evidence concerns the gene AKT1 and neoplasm.